Publication
Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson's disease using electrophysiological measurements of visual processing
Ostergaard, F. G., Himmelberg, M. M., Laursen, B., Siebner, H. R., Wade, A. R. & Christensen, K. V., 17-Jul-2020, In : Scientific Reports. 10, 1, 14 p., 11869.Research output: Contribution to journal › Article › Academic › peer-review
APA
Author
Harvard
Standard
Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson's disease using electrophysiological measurements of visual processing. / Ostergaard, Freja Gam; Himmelberg, Marc M.; Laursen, Bettina; Siebner, Hartwig R.; Wade, Alex R.; Christensen, Kenneth Vielsted.
In: Scientific Reports, Vol. 10, No. 1, 11869, 17.07.2020.Research output: Contribution to journal › Article › Academic › peer-review
Vancouver
BibTeX
}
RIS
TY - JOUR
T1 - Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson's disease using electrophysiological measurements of visual processing
AU - Ostergaard, Freja Gam
AU - Himmelberg, Marc M.
AU - Laursen, Bettina
AU - Siebner, Hartwig R.
AU - Wade, Alex R.
AU - Christensen, Kenneth Vielsted
PY - 2020/7/17
Y1 - 2020/7/17
N2 - Biomarkers suitable for early diagnosis and monitoring disease progression are the cornerstone of developing disease-modifying treatments for neurodegenerative diseases such as Parkinson’s disease (PD). Besides motor complications, PD is also characterized by deficits in visual processing. Here, we investigate how virally-mediated overexpression of α-synuclein in the substantia nigra pars compacta impacts visual processing in a well-established rodent model of PD. After a unilateral injection of vector, human α-synuclein was detected in the striatum and superior colliculus (SC). In parallel, there was a significant delay in the latency of the transient VEPs from the affected side of the SC in late stages of the disease. Inhibition of leucine-rich repeat kinase using PFE360 failed to rescue the VEP delay and instead increased the latency of the VEP waveform. A support vector machine classifier accurately classified rats according to their `disease state’ using frequency-domain data from steady-state visual evoked potentials (SSVEP). Overall, these findings indicate that the latency of the rodent VEP is sensitive to changes mediated by the increased expression of α-synuclein and especially when full overexpression is obtained, whereas the SSVEP facilitated detection of α-synuclein across reflects all stages of PD model progression.
AB - Biomarkers suitable for early diagnosis and monitoring disease progression are the cornerstone of developing disease-modifying treatments for neurodegenerative diseases such as Parkinson’s disease (PD). Besides motor complications, PD is also characterized by deficits in visual processing. Here, we investigate how virally-mediated overexpression of α-synuclein in the substantia nigra pars compacta impacts visual processing in a well-established rodent model of PD. After a unilateral injection of vector, human α-synuclein was detected in the striatum and superior colliculus (SC). In parallel, there was a significant delay in the latency of the transient VEPs from the affected side of the SC in late stages of the disease. Inhibition of leucine-rich repeat kinase using PFE360 failed to rescue the VEP delay and instead increased the latency of the VEP waveform. A support vector machine classifier accurately classified rats according to their `disease state’ using frequency-domain data from steady-state visual evoked potentials (SSVEP). Overall, these findings indicate that the latency of the rodent VEP is sensitive to changes mediated by the increased expression of α-synuclein and especially when full overexpression is obtained, whereas the SSVEP facilitated detection of α-synuclein across reflects all stages of PD model progression.
KW - SUBSTANTIA-NIGRA
KW - SUPERIOR COLLICULUS
KW - EVOKED-POTENTIALS
KW - GAIN-CONTROL
KW - PROJECTION
KW - PATHOLOGY
KW - DOPAMINE
U2 - 10.1038/s41598-020-68808-3
DO - 10.1038/s41598-020-68808-3
M3 - Article
VL - 10
JO - Scientific Reports
JF - Scientific Reports
SN - 2045-2322
IS - 1
M1 - 11869
ER -
ID: 135582793